A retrospective study was conducted with adult inpatients over age 18 years who were initiated on vancomycin between August 1 and September 30, 2006 (preimplementation group), and between March 1 and ...
In an in vitrostudy, fixed-combination fortified vancomycin and amikacin ophthalmic solutions (VA solution) had the same potency and stable physical properties as the separate components. In this ...